Imiquimod cream 5% is indicated for the topical treatment of superficial basal cell carcinoma, actinic keratosis, and external genital warts, contraindicated in patients with hypersensitivity to imiquimod or any component of the formulation, and common side effects include local erythema, itching, and burning, while drug interactions may occur with immunosuppressive agents.